Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03298945 · ClinicalTrials.gov registry record · Phase 4
Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens
A Phase 4 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,239
- Enrollment target
NCT03298945: Completed Phase 4 study, sponsored by VA Office of Research and Development.
NCT03298945 is a Phase 4 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 2,239 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (332% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03298945, a Phase 4 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,239 participants
- Enrollment target
Study Summary
From the patients' perspective, the most formidable part of the colonoscopy experience is the process of bowel cleansing. A poorly tolerated bowel preparation regimen often leads to incompletion of scheduled colonoscopies which in turn undermines the effectiveness of colonoscopy, increases cost, and decreases patient satisfaction. The current standard bowel preparation in the VA is of larger volume and less palatable than another commonly used bowel preparation regimen. The investigators propose to compare these two commonly used bowel preparations with respect to the overall completion rate of scheduled colonoscopies in a real-world VA practice setting. The results of the study can be immediately applied to maximize the effectiveness of colonoscopy and increase patient satisfaction in the VA.
Primary Outcome
The completion rate of scheduled colonoscopy will be defined as the proportion of patients who show up for their scheduled colonoscopy and have endoscopist-rated "adequate" bowel preparation quality, among those scheduled for a colonoscopy.
Interventions
- DRUG Golytely
- DRUG Miralax-Gatorade Prep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,239 participants |
| Start Date | 2018-12-13 |
| Est. Completion | 2024-06-30 |
| Phase | Phase 4 |
What the finished NCT03298945 record still lists
NCT03298945 is an interventional study that assigns participants to a tested intervention. Its 2,239 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (332% higher).
The record links to 0 conditions, and to 2 interventions - of which Golytely is the first listed.
NCT03298945 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03298945 about?
NCT03298945 is a clinical study titled "Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens". From the patients' perspective, the most formidable part of the colonoscopy experience is the process of bowel cleansing. A poorly tolerated bowel preparation regimen often leads to incompletion of scheduled colonoscopies which in turn undermines the effectiveness of colonoscopy, increases cost, and...
What is the current status of trial NCT03298945?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,239 participants. The study started on 2018-12-13. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03298945?
The interventions under investigation include: Golytely (DRUG), Miralax-Gatorade Prep (DRUG).
Who is sponsoring clinical trial NCT03298945?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03298945's enrollment target sits among peer trials
2,239 32nd of 2000 higher than 1,969 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI